122 related articles for article (PubMed ID: 38703129)
1. Salivary metabolomic identification of biomarker candidates for oral melanoma and oral squamous cell carcinoma in dogs.
Ploypetch S; Luo X; Zhao S; Roytrakul S; Li L; Suriyaphol G
J Vet Intern Med; 2024 May; ():. PubMed ID: 38703129
[TBL] [Abstract][Full Text] [Related]
2. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
[TBL] [Abstract][Full Text] [Related]
3. In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors.
Ploypetch S; Roytrakul S; Phaonakrop N; Kittisenachai S; Leetanasaksakul K; Pisamai S; Kalpravidh C; Rungsipipat A; Suriyaphol G
BMC Vet Res; 2020 Sep; 16(1):335. PubMed ID: 32928212
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of canine oral tumor tissues using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC MS/MS) approaches.
Pisamai S; Roytrakul S; Phaonakrop N; Jaresitthikunchai J; Suriyaphol G
PLoS One; 2018; 13(7):e0200619. PubMed ID: 30001383
[TBL] [Abstract][Full Text] [Related]
5. Development of Chemical Isotope Labeling LC-MS for Milk Metabolomics: Comprehensive and Quantitative Profiling of the Amine/Phenol Submetabolome.
Mung D; Li L
Anal Chem; 2017 Apr; 89(8):4435-4443. PubMed ID: 28306241
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive and Quantitative Profiling of the Human Sweat Submetabolome Using High-Performance Chemical Isotope Labeling LC-MS.
Hooton K; Han W; Li L
Anal Chem; 2016 Jul; 88(14):7378-86. PubMed ID: 27351466
[TBL] [Abstract][Full Text] [Related]
7. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
Shen W; Han W; Li Y; Meng Z; Cai L; Li L
Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
[TBL] [Abstract][Full Text] [Related]
8. DnsID in MyCompoundID for rapid identification of dansylated amine- and phenol-containing metabolites in LC-MS-based metabolomics.
Huan T; Wu Y; Tang C; Lin G; Li L
Anal Chem; 2015 Oct; 87(19):9838-45. PubMed ID: 26327437
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma.
Ohshima M; Sugahara K; Kasahara K; Katakura A
Oncol Rep; 2017 May; 37(5):2727-2734. PubMed ID: 28393236
[TBL] [Abstract][Full Text] [Related]
10. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
[TBL] [Abstract][Full Text] [Related]
11. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry.
Wang Q; Gao P; Cheng F; Wang X; Duan Y
Talanta; 2014 Feb; 119():299-305. PubMed ID: 24401418
[TBL] [Abstract][Full Text] [Related]
12. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
13. Identification of Possible Salivary Metabolic Biomarkers and Altered Metabolic Pathways in South American Patients Diagnosed with Oral Squamous Cell Carcinoma.
de Sá Alves M; de Sá Rodrigues N; Bandeira CM; Chagas JFS; Pascoal MBN; Nepomuceno GLJT; da Silva Martinho H; Alves MGO; Mendes MA; Dias M; Alves LAC; Almeida JD
Metabolites; 2021 Sep; 11(10):. PubMed ID: 34677365
[TBL] [Abstract][Full Text] [Related]
14. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
Wang Q; Gao P; Wang X; Duan Y
Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
[TBL] [Abstract][Full Text] [Related]
15. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
16. Dansylation isotope labeling liquid chromatography mass spectrometry for parallel profiling of human urinary and fecal submetabolomes.
Su X; Wang N; Chen D; Li Y; Lu Y; Huan T; Xu W; Li L; Li L
Anal Chim Acta; 2016 Jan; 903():100-9. PubMed ID: 26709303
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic Coverage of Chemical-Group-Submetabolome Analysis: Group Classification and Four-Channel Chemical Isotope Labeling LC-MS.
Zhao S; Li H; Han W; Chan W; Li L
Anal Chem; 2019 Sep; 91(18):12108-12115. PubMed ID: 31441644
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
20. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]